Epidemiology & Genomics Research Program
Supporting research in human populations to understand determinants of cancer occurrence and outcomes and translating findings to clinical and public health interventions.
Funding Opportunities
Pragmatic Trials Across the Cancer Control Continuum
PAR-22-256 (UG3/UH3 - Clinical Trial Required)
Expires November 18, 2025
for this funding opportunity.
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility
PAR-22-083 (R01 - Clinical Trial Not Allowed) and PAR-22-084 (R21 - Clinical Trial Not Allowed)
Expires May 8, 2025
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts
PAR-22-161 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
.
Research Opportunities in Established Cancer Epidemiology Cohort Studies
PAR-22-162 (U01 - Clinical Trial Not Allowed)
Expires March 1, 2025
.
Exploratory Grants in Cancer Control
PAR-21-341 (R21 - Clinical Trial Optional)
Expires October 9, 2024
Time-Sensitive Obesity Policy and Program Evaluation
PAR-21-305 (R01 - Clinical Trial Not Allowed)
Expires September 11, 2024
Notice of Special Interest: Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research
NOT-CA-22-037
Expires March 9, 2024
Modular R01s in Cancer Control and Population Sciences
PAR-21-190 (R01 - Clinical Trial Optional)
Expires March 8, 2024
Notice of Special Interest: Understanding the Effects of Cancer and Cancer Treatment on Aging Trajectories and Aging Outcomes
NOT-CA-21-031
Expires January 8, 2024
Assay Validation of High Quality Markers for Clinical Studies in Cancer
PAR-20-313 (UH2/UH3 - Clinical Trial Not Allowed) and PAR-20-314 (UH3 - Clinical Trials Not Allowed)
Expires October 11, 2023
Notice of Special Interest: Dietary, Physical Activity, Sedentary Behavior and Sleep Assessment Methodologies Among Infants and Young Children (Birth to 5 years) through Adults
NOT-CA-21-108
Expires May 08, 2023
Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms
RFA-CA-22-052 (U01 - Clinical Trial Not Allowed) and RFA-CA-22-053 (U24 - Clinical Trial Not Allowed)
Expires February 18, 2023
on these funding opportunities.
Featured Resource
View Past Events in the EGRP Video Library
The EGRP video library contains recordings from more than 100 scientific webinars and meetings organized by our program.
Featured Event
Registration Open for February 2023 Virtual Meeting
NCI is planning a virtual meeting to identify and discuss how best to address scientific challenges and opportunities for understanding the path from genetic variation to cancer phenotype. This meeting is open to the public and free to attend, but registration is required to access the virtual event. Stay tuned for more details about the agenda.
What's New
Connect With Us
Subscribe for Updates
Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.
Need Help?
EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.
Email Us(240) 276-6730